Ghent University Academic Bibliography

Advanced

Early effects of human papillomavirus vaccination in Belgium

Mireille Merckx UGent, Davy Vanden Broeck UGent, Ina Benoy, Christophe Depuydt, Steven Weyers UGent and Marc Arbyn (2015) EUROPEAN JOURNAL OF CANCER PREVENTION. 24(4). p.340-342
abstract
Human papillomavirus (HPV) vaccination has been reimbursed in Belgium since 2007 for girls (12-15 years), extended to girls up to 18 years in 2008. This study assesses the trend of HPV 16/18 infections in women less than 25 years of age participating in opportunistic cervical cancer screening. A significant reduction in the prevalence of HPV 16 [relative risk (RR)=0.61, 95% confidence interval=0.39-0.95] and a nonsignificant reduction in HPV 18 (RR=0.65, 95% confidence interval=0.29-1.48) was found in the youngest group (15-19 years). The prevalences in the older age group did not change significantly. These findings show the early effects of HPV vaccination and confirm the effectiveness of immunization in a real-life setting.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
surveillance, HPV vaccine impact, HPV vaccine, cervical cancer, adolescents, CROSS-PROTECTIVE EFFICACY, GRADE CERVICAL LESIONS, METAANALYSIS, PREVENTION, INFECTION, CANCER
journal title
EUROPEAN JOURNAL OF CANCER PREVENTION
Eur. J. Cancer Prev.
volume
24
issue
4
pages
340 - 342
Web of Science type
Article
Web of Science id
000355658400011
JCR category
ONCOLOGY
JCR impact factor
2.415 (2015)
JCR rank
133/213 (2015)
JCR quartile
3 (2015)
ISSN
0959-8278
DOI
10.1097/CEJ.0000000000000067
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
5765612
handle
http://hdl.handle.net/1854/LU-5765612
date created
2014-11-28 09:28:40
date last changed
2016-12-19 15:46:06
@article{5765612,
  abstract     = {Human papillomavirus (HPV) vaccination has been reimbursed in Belgium since 2007 for girls (12-15 years), extended to girls up to 18 years in 2008. This study assesses the trend of HPV 16/18 infections in women less than 25 years of age participating in opportunistic cervical cancer screening. A significant reduction in the prevalence of HPV 16 [relative risk (RR)=0.61, 95\% confidence interval=0.39-0.95] and a nonsignificant reduction in HPV 18 (RR=0.65, 95\% confidence interval=0.29-1.48) was found in the youngest group (15-19 years). The prevalences in the older age group did not change significantly. These findings show the early effects of HPV vaccination and confirm the effectiveness of immunization in a real-life setting.},
  author       = {Merckx, Mireille and Vanden Broeck, Davy and Benoy, Ina and Depuydt, Christophe and Weyers, Steven and Arbyn, Marc},
  issn         = {0959-8278},
  journal      = {EUROPEAN JOURNAL OF CANCER PREVENTION},
  keyword      = {surveillance,HPV vaccine impact,HPV vaccine,cervical cancer,adolescents,CROSS-PROTECTIVE EFFICACY,GRADE CERVICAL LESIONS,METAANALYSIS,PREVENTION,INFECTION,CANCER},
  language     = {eng},
  number       = {4},
  pages        = {340--342},
  title        = {Early effects of human papillomavirus vaccination in Belgium},
  url          = {http://dx.doi.org/10.1097/CEJ.0000000000000067},
  volume       = {24},
  year         = {2015},
}

Chicago
Merckx, Mireille, Davy Vanden Broeck, Ina Benoy, Christophe Depuydt, Steven Weyers, and Marc Arbyn. 2015. “Early Effects of Human Papillomavirus Vaccination in Belgium.” European Journal of Cancer Prevention 24 (4): 340–342.
APA
Merckx, Mireille, Vanden Broeck, D., Benoy, I., Depuydt, C., Weyers, S., & Arbyn, M. (2015). Early effects of human papillomavirus vaccination in Belgium. EUROPEAN JOURNAL OF CANCER PREVENTION, 24(4), 340–342.
Vancouver
1.
Merckx M, Vanden Broeck D, Benoy I, Depuydt C, Weyers S, Arbyn M. Early effects of human papillomavirus vaccination in Belgium. EUROPEAN JOURNAL OF CANCER PREVENTION. 2015;24(4):340–2.
MLA
Merckx, Mireille, Davy Vanden Broeck, Ina Benoy, et al. “Early Effects of Human Papillomavirus Vaccination in Belgium.” EUROPEAN JOURNAL OF CANCER PREVENTION 24.4 (2015): 340–342. Print.